Trials / Active Not Recruiting
Active Not RecruitingNCT04916249
Testing an Herbal Pain Relief Patch to Reduce Pain in Cancer Survivors
Tibetree Pain-Relieving Plaster for Musculoskeletal Pain Among Cancer Survivors
- Status
- Active Not Recruiting
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 68 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to find out whether Tibetree Pain Relieving Plaster, an herbal pain relief patch, may be able to reduce this pain. Tibetree Pain Relieving Plaster is available as an over-the-counter (non-prescription) treatment for the temporary relief of minor aches and pains in muscles and joints. This study is the first to test this treatment in people who have had cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tibetree Pain Relieving Plaster | Participants who provide informed consent in the trial will receive either the Tibetree pain relieving plaster if randomized into the intervention arm, or an identical placebo plaster if randomized into the control arm. The treatment course for both arms are identical. Participants will be instructed to apply the plaster directly to the skin overlying the area of pain for 6 hours once daily for 14 consecutive days. |
| OTHER | Placebo | Participants who provide informed consent in the trial will receive either the Tibetree pain relieving plaster if randomized into the intervention arm, or an identical placebo plaster if randomized into the control arm. The treatment course for both arms are identical. Participants will be instructed to apply the plaster directly to the skin overlying the area of pain for 6 hours once daily for 14 consecutive days. |
Timeline
- Start date
- 2021-05-28
- Primary completion
- 2026-05-28
- Completion
- 2026-05-28
- First posted
- 2021-06-07
- Last updated
- 2025-06-17
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04916249. Inclusion in this directory is not an endorsement.